Table 4 MACCE-correlated factors in diabetic and non-diabetic subjects
From: Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients
DM (n = 44) | Non-DM (n = 46) | |||||
|---|---|---|---|---|---|---|
With MACCE (n = 22) | Without MACCE (n = 22) | p value | With MACCE (n = 11) | Without MACCE (n = 35) | p value | |
Age (year) | 61.9 ± 12.8 | 63.1 ± 12.6 | 0.75 | 67.4 ± 9.6 | 63.4 ± 11.4 | 0.41 |
HD duration (months) | 46.0 ± 11.6 | 46.6 ± 10.5 | 0.97 | 102.1 ± 81.8 | 86.3 ± 86.1 | 0.83 |
Alb (g/dl) | 3.9 ± 0.4 | 4.0 ± 0.5 | 0.60 | 3.7 ± 0.4 | 3.9 ± 0.5 | 0.86 |
Hb (g/dl) | 10.5 ± 1.1 | 10.7 ± 1.0 | 0.61 | 10.3 ± 0.8 | 10.4 ± 1.3 | 0.81 |
Fluid removal (kg) | 2.4 ± 1.5 | 2.1 ± 1.1 | 0.41 | 2.2 ± 1.1 | 2.2 ± 1.2 | 0.91 |
SDNN (Low,n%) | 16 (72.7%) | 11 (50.0%) | 0.12 | 7 (63.6%) | 11 (31.4%) | 0.05 |
SDANN (Low,n%) | 16 (72.7%) | 13 (59.1%) | 0.34 | 8 (72.7%) | 9 (25.7%) | 0.01 |